By Stephen Nakrosis
Shares of BriaCell Therapeutics were trading at all-time lows in Monday's after-hours market, following news the company plans to sell shares in a best-efforts public offering.
After the bell, shares were trading 22% lower at $3.90. Although the stock finished the day's regular session at $5.04, relatively flat, shares were at an all-time low of $4.66 during Monday's session.
The biotechnology company said it will use proceeds from the offering primarily for working capital requirements, general corporate purposes, and the advancement of business objectives.
BriaCell said it is developing novel immunotherapies to transform cancer care.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
February 03, 2025 17:27 ET (22:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。